Correlation Between Pasithea Therapeutics and Neurosense Therapeutics
Can any of the company-specific risk be diversified away by investing in both Pasithea Therapeutics and Neurosense Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pasithea Therapeutics and Neurosense Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pasithea Therapeutics Corp and Neurosense Therapeutics, you can compare the effects of market volatilities on Pasithea Therapeutics and Neurosense Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pasithea Therapeutics with a short position of Neurosense Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pasithea Therapeutics and Neurosense Therapeutics.
Diversification Opportunities for Pasithea Therapeutics and Neurosense Therapeutics
0.23 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Pasithea and Neurosense is 0.23. Overlapping area represents the amount of risk that can be diversified away by holding Pasithea Therapeutics Corp and Neurosense Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neurosense Therapeutics and Pasithea Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pasithea Therapeutics Corp are associated (or correlated) with Neurosense Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neurosense Therapeutics has no effect on the direction of Pasithea Therapeutics i.e., Pasithea Therapeutics and Neurosense Therapeutics go up and down completely randomly.
Pair Corralation between Pasithea Therapeutics and Neurosense Therapeutics
Assuming the 90 days horizon Pasithea Therapeutics Corp is expected to generate 1.31 times more return on investment than Neurosense Therapeutics. However, Pasithea Therapeutics is 1.31 times more volatile than Neurosense Therapeutics. It trades about -0.04 of its potential returns per unit of risk. Neurosense Therapeutics is currently generating about -0.3 per unit of risk. If you would invest 2.10 in Pasithea Therapeutics Corp on August 31, 2024 and sell it today you would lose (0.07) from holding Pasithea Therapeutics Corp or give up 3.33% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 47.83% |
| Values | Daily Returns |
Pasithea Therapeutics Corp vs. Neurosense Therapeutics
Performance |
| Timeline |
| Pasithea Therapeutics |
| Neurosense Therapeutics |
Pasithea Therapeutics and Neurosense Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pasithea Therapeutics and Neurosense Therapeutics
The main advantage of trading using opposite Pasithea Therapeutics and Neurosense Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pasithea Therapeutics position performs unexpectedly, Neurosense Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neurosense Therapeutics will offset losses from the drop in Neurosense Therapeutics' long position.| Pasithea Therapeutics vs. Cue Biopharma | Pasithea Therapeutics vs. Eliem Therapeutics | Pasithea Therapeutics vs. Inhibrx | Pasithea Therapeutics vs. Molecular Partners AG |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |